Tenaya Therapeutics
(NASDAQ) TNYA
Tenaya Therapeutics Financials at a Glance
Market Cap
$144.33M
Revenue (TTM)
$0.00
Net Income (TTM)
$90.60M
EPS (TTM)
$-0.63
P/E Ratio
-1.06
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.67
Volume
24,301
Open
$0.69
Price
$0.67
Volume
24,301
Open
$0.69
Previous Close
$0.67
Daily Range
$0.66 - $0.70
52-Week Range
$0.36 - $2.35
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.67
Volume
24,301
Open
$0.69
Previous Close
$0.67
Daily Range
$0.66 - $0.70
52-Week Range
$0.36 - $2.35
TNYA News
TNYA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Tenaya Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
70
CEO
Faraz Ali, MBA
Website
www.tenayatherapeutics.comHeadquarters
South San Francisco, CA 94080, US
TNYA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-84%
Return on Capital
-71%
Return on Assets
-62%
Earnings Yield
-94.34%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$144.33M
Shares Outstanding
217.00M
Volume
24.30K
Short Interest
0.00%
Avg. Volume
4.42M
Financials (TTM)
Gross Profit
$8.44M
Operating Income
$93.33M
EBITDA
$84.89M
Operating Cash Flow
$68.26M
Capital Expenditure
$618.00K
Free Cash Flow
$68.88M
Cash & ST Invst.
$100.55M
Total Debt
$10.83M
Tenaya Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$3.95M
N/A
Gross Margin
0.00%
N/A
Market Cap
$144.33M
N/A
Market Cap/Employee
$1.49M
N/A
Employees
97
N/A
Net Income
$20.18M
+15.4%
EBITDA
$18.95M
+16.0%
Quarterly Fundamentals
Net Cash
$89.72M
+87.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$7.81M
-27.9%
Short Term Debt
$3.02M
+8.7%
Return on Assets
-61.66%
N/A
Return on Invested Capital
-70.98%
N/A
Free Cash Flow
$14.01M
+24.7%
Operating Cash Flow
$13.94M
+24.2%